Molecular Imaging Program
Imaging methods have emerged as powerful tools in diagnosing and monitoring disease. Molecular imaging allows biological processes to be visualized, quantified and tracked over time resulting in earlier detection of disease and better estimation of the stage of disease. Alseres Pharmaceuticals' Molecular Imaging Program is focused on developing molecular imaging agents using SPECT that may aid physicians in diagnosing and monitoring disorders of the central nervous system such as Parkinson's Disease and ADHD.